Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

Université de Sherbrooke

$30,000.00

Deciphering the alternative splicing regulatory program driving the myofibroblast state

EF 2021-22

Résumé
Alternative splicing is a powerful mechanism that expands the proteome diversity by allowing the transcription of multiple messenger RNAs from a single gene. Numerous examples have illustrated the functional impact of alternative splicing in the literature. There is also a high level of understanding of the major factors influencing a splicing decision (e.g. RNA sequence in cis and RNA binding factors acting in trans), recently culminating into a "splicing code". However, there is not much known about the upstream mechanisms controlling the expression/activity of splicing factors and even less linking extracellular factors to alternative splicing regulation. My laboratory is interested in deciphering the regulatory mechanisms upstream of an alternative splicing network orchestrating key developmental programs in humans. Following injury, fibroblasts follow a developmental program to differentiate into myofibroblasts. This way, they acquire enhanced contractile properties through the assembly of the characteristic stress fibers, and additional extracellular matrix secretion capacity necessary to regenerate normal tissue function. This can be recapitulated in vitro by stimulating fibroblasts with the tumor growth factor beta, the master regulator of myofibroblast differentiation. We discovered multiple alternatively spliced isoform associated to the myofibroblast state including the well-established isoform of fibronectin called fibronectin extra domain A critical to the tumor growth factor beta-induced myofibroblast state. In addition, a proteomic approach identified several tumor growth factor beta-regulated splicing factors in myofibroblasts. Still, the depth of this alternative splicing program and ultimately its upstream regulatory control (what's happening between the tumor growth factor beta and the splicing factors driving the myofibroblast phenotype) is unknown. In this NSERC - Discovery grant, I, therefore, hypothesize that upon tumor growth factor beta stimulation, a regulatory network controlling the expression/activity of a set of splicing factors leads to the coordinate expression of specific myofibroblast splicing isoforms that are critical for myofibroblast differentiation. More precisely, we will complete the following specific aims with the help of a Ph.D. student and two undergraduate students: AIM 1 To determine the alternative splicing events driving myofibroblast differentiation AIM 2 To determine the myofibroblast splicing factors driving myofibroblast differentiation Overall, this study will generate a complete portrait of how key developmental program driven by an alternative splicing network are regulated and will be a unique opportunity for junior scientists in my lab to get hands-on training on cutting-edge technologies.
Programme
Discovery Grants Program - Individual
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
RGPIN-2021-04035
Name nom
Brosseau, Jean-Philippe
Department département
Biochemistry and Functional Genomic
Organization id
68
Institution établissement
Université de Sherbrooke
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2021
Competition year année de concours
2021
Award amount
30000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
5303
Research subject group en
Molecular biology
Research subject group fr
Biologie moléculaire
Research subject en
Gene regulation
Research subject fr
Régulation des gènes
Installment
inst:1
Partie
1
Nb partie
5
Application title
Deciphering the alternative splicing regulatory program driving the myofibroblast state
Keyword
NSERC
Application summary
Alternative splicing is a powerful mechanism that expands the proteome diversity by allowing the transcription of multiple messenger RNAs from a single gene. Numerous examples have illustrated the functional impact of alternative splicing in the literature. There is also a high level of understanding of the major factors influencing a splicing decision (e.g. RNA sequence in cis and RNA binding factors acting in trans), recently culminating into a "splicing code". However, there is not much known about the upstream mechanisms controlling the expression/activity of splicing factors and even less linking extracellular factors to alternative splicing regulation. My laboratory is interested in deciphering the regulatory mechanisms upstream of an alternative splicing network orchestrating key developmental programs in humans. Following injury, fibroblasts follow a developmental program to differentiate into myofibroblasts. This way, they acquire enhanced contractile properties through the assembly of the characteristic stress fibers, and additional extracellular matrix secretion capacity necessary to regenerate normal tissue function. This can be recapitulated in vitro by stimulating fibroblasts with the tumor growth factor beta, the master regulator of myofibroblast differentiation. We discovered multiple alternatively spliced isoform associated to the myofibroblast state including the well-established isoform of fibronectin called fibronectin extra domain A critical to the tumor growth factor beta-induced myofibroblast state. In addition, a proteomic approach identified several tumor growth factor beta-regulated splicing factors in myofibroblasts. Still, the depth of this alternative splicing program and ultimately its upstream regulatory control (what's happening between the tumor growth factor beta and the splicing factors driving the myofibroblast phenotype) is unknown. In this NSERC - Discovery grant, I, therefore, hypothesize that upon tumor growth factor beta stimulation, a regulatory network controlling the expression/activity of a set of splicing factors leads to the coordinate expression of specific myofibroblast splicing isoforms that are critical for myofibroblast differentiation. More precisely, we will complete the following specific aims with the help of a Ph.D. student and two undergraduate students: AIM 1 To determine the alternative splicing events driving myofibroblast differentiation AIM 2 To determine the myofibroblast splicing factors driving myofibroblast differentiation Overall, this study will generate a complete portrait of how key developmental program driven by an alternative splicing network are regulated and will be a unique opportunity for junior scientists in my lab to get hands-on training on cutting-edge technologies.